Immutep Berita Eulerpool

Immutep Berita Saham

Immutep diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Immutep kami rangkum di sini.

• 17 Desember ·

  Yahoo
  Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761
• 16 Desember ·

  Yahoo
  Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to MHC Class II
• 13 Desember ·

  Yahoo
  Immutep announces results from Cohort B of TACTI-003 trial
• 12 Desember ·

  Yahoo
  Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024
• 10 Desember ·

  Yahoo
  Immutep Announces Initiation of TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
• 6 Desember ·

  Yahoo
  Exclusive: Prima, Mexico-based manufacturing and supply chain integrator, reveals it has raised $42.5 million
• 15 November ·

  SeekingAlpha
  Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients
• 14 November ·

  Yahoo
  Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
• 14 November ·

  Yahoo
  Positive Data from Phase II Trial in Soft Tissue Sarcoma Presented at CTOS 2024 Annual Meeting
• 6 November ·

  Yahoo
  Immutep (ASX:IMM) shareholders have endured a 51% loss from investing in the stock three years ago